Study Stopped
Lack of subjects enrolled
The Study on Bacterial Load Following Open-to-air Management in Burn Patients.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Burns are one of the common forms of trauma and are a cause of unintentional death and injury. Management of burns becomes complex due to multiple associated complications, for instance, secondary infection of burn wounds is the most common complication associated with burn injuries. Treatment of bacterial infections with antibiotics is becoming more challenging due to the development of multidrug-resistance. Hence, there is a critical need to investigate and establish non-antibiotic approaches to prevent colonization, control growth, and eliminate bacteria from burn wounds. Recent studies have explored the beneficial effects of open-to-air strategies on wound healing. Based on the evidence, the investigators hypothesize that bacterial load in burn wounds will be lowered when treated with an open-to-air strategy compared to the traditional closed wound approach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2020
CompletedFirst Posted
Study publicly available on registry
August 6, 2020
CompletedStudy Start
First participant enrolled
November 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 9, 2021
CompletedJanuary 5, 2022
December 1, 2021
7 months
July 29, 2020
December 14, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
The bacterial load at baseline for each treatment
Scrapings of the superficial wound exudate and debris will be obtained at baseline (i.e., the 0-time point before implementing any the tested wound care management option) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.
At baseline
The bacterial load on day 1 for each treatment
Scrapings of the superficial wound exudate and debris will be obtained on day 1 (about 24 hours after obtaining samples for baseline measurement) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.
On day 1
The bacterial load on day 2 for each treatment
Scrapings of the superficial wound exudate and debris will be obtained on day 2 (about 48 hours after obtaining samples for baseline measurement) from both wound sites of each patient. The colony-forming units (CFUs) will be enumerated and CFUs/g will be calculated for treatment and control.
On day 2
Difference in change in bacterial load for day 1
Change in bacterial load from baseline and day 1 and compared between treatment and control groups.
Change in bacterial load from baseline and day 1
Difference in change in bacterial load for day 2
Change in bacterial load from baseline and day 2 and compared between treatment and control groups.
Change in bacterial load from baseline and day 2
Secondary Outcomes (3)
Prevalence of bacterial species at baseline for each treatment
At baseline
Prevalence of bacterial species on day 1 for each treatment
On day 1
Prevalence of bacterial species on day 1 for each treatment
On day 2
Study Arms (2)
The experimental group
EXPERIMENTALThe experimental group will consist of wounds treated with the open-to-air strategy.
The control group
OTHERThe control group will consist of wounds treated with traditional closed-wound management with dressings soaked in topical antimicrobial solutions.
Interventions
In open-to-air management, the wound will be washed with a chlorhexidine solution and leave the wound open, or portion of the wound assigned to OTA, to the environment. An electric heat lamp (model no. 53103, 250W, Brandt Industries LLC, Bronx, NY) will be placed at as close to 1 yard (0.91 m) as possible from the wound after daily wound care for 24 hours (+/- 6 hours) to promote drying. However, to prevent excessive drying an hourly spritz of topical solution, e.g., DuoDERM® Hydroactive® gel (ConvaTec Oklahoma City, OK) will be used at the bedside.
In traditional closed-wound management, once a day the wound will be washed with a chlorhexidine solution and closed with a non-adherent dressing such as ADAPTIC® (Acelity, San Antonio, TX) soaked in topical antimicrobial solutions, ointments, and creams designed to promote wound healing.
Eligibility Criteria
You may qualify if:
- Age 18 to 89
- Burn patients with TBSA≥ 20%
- Any suspicion of skin colonization or infection based on a positive result of microbiologic testing. Testing would only be performed if the attending surgeon treating the patient had a clinical suspicion of wound infection.
You may not qualify if:
- \. Children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Tech University Health Sciences Center
Lubbock, Texas, 79430, United States
Related Publications (2)
Yang D, Davies A, Burge B, Watkins P, Dissanaike S. Open-to-Air Is a Viable Option for Initial Wound Care in Necrotizing Soft Tissue Infection that Allows Early Detection of Recurrence without Need for Painful Dressing Changes or Return to Operating Room. Surg Infect (Larchmt). 2018 Jan;19(1):65-70. doi: 10.1089/sur.2017.080. Epub 2017 Dec 6.
PMID: 29211657RESULTDai T, Gupta A, Huang YY, Yin R, Murray CK, Vrahas MS, Sherwood ME, Tegos GP, Hamblin MR. Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother. 2013 Mar;57(3):1238-45. doi: 10.1128/AAC.01652-12. Epub 2012 Dec 21.
PMID: 23262998RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2020
First Posted
August 6, 2020
Study Start
November 1, 2020
Primary Completion
June 9, 2021
Study Completion
June 9, 2021
Last Updated
January 5, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share